Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

This publication has 19 references indexed in Scilit:

• Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease
  Published by Elsevier ,2014
• Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary
  Gynecologic Oncology, 2007
• Advanced stage clear-cell epithelial ovarian cancer: The Hellenic cooperative oncology group experience
  Gynecologic Oncology, 2006
• Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
  British Journal of Cancer, 2006
• Treatment options in the management of ovarian cancer
  Expert Opinion on Pharmacotherapy, 2005
• Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy
  Cancer, 1996
• The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin
  Cancer Letters, 1996
• Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III Disease
  Gynecologic Oncology, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early Stages
  Gynecologic Oncology, 1993